ZEB1 promoted the expansion of Th17 cells via upregulating factors (IL-23 and TGF-β), which secretes IL-17 cytokines in AML cells, thereby promoting tumor growth and immune suppression, thus contributing to AML progression. The gene discussed is IL17A; the disease is acute myeloid leukemia.